Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Medicine (Baltimore) ; 96(14): e6275, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28383402

ABSTRACT

We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results.


Subject(s)
Anti-Retroviral Agents/administration & dosage , HIV Infections/drug therapy , Adult , Female , Humans , Male , Middle Aged , Treatment Outcome
2.
Horm Behav ; 66(2): 283-97, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24768711

ABSTRACT

Anabolic androgenic steroids (AAS) are taken by both sexes to enhance athletic performance and body image, nearly always in conjunction with an exercise regime. Although taken to improve physical attributes, chronic AAS use can promote negative behavior, including anxiety. Few studies have directly compared the impact of AAS use in males versus females or assessed the interaction of exercise and AAS. We show that AAS increase anxiety-like behaviors in female but not male mice and that voluntary exercise accentuates these sex-specific differences. We also show that levels of the anxiogenic peptide corticotrophin releasing factor (CRF) are significantly greater in males, but that AAS selectively increase CRF levels in females, thus abrogating this sex-specific difference. Exercise did not ameliorate AAS-induced anxiety or alter CRF levels in females. Exercise was anxiolytic in males, but this behavioral outcome did not correlate with CRF levels. Brain-derived neurotrophic factor (BDNF) has also been implicated in the expression of anxiety. As with CRF, levels of hippocampal BDNF mRNA were significantly greater in males than females. AAS and exercise were without effect on BDNF mRNA in females. In males, anxiolytic effects of exercise correlated with increased BDNF mRNA, however AAS-induced changes in BDNF mRNA and anxiety did not. In sum, we find that AAS elicit sex-specific differences in anxiety and that voluntary exercise accentuates these differences. In addition, our data suggest that these behavioral outcomes may reflect convergent actions of AAS and exercise on a sexually differentiated CRF signaling system within the extended amygdala.


Subject(s)
Anabolic Agents/toxicity , Androgens/toxicity , Anxiety/chemically induced , Anxiety/psychology , Physical Conditioning, Animal/physiology , Sexual Behavior, Animal/physiology , Steroids/toxicity , Animals , Body Weight/drug effects , Choice Behavior , Corticotropin-Releasing Hormone/metabolism , Female , Male , Mice , Mice, Inbred C57BL , Reflex, Startle/drug effects , Sex Characteristics , Social Behavior
3.
J Pharm Sci ; 103(5): 1331-6, 2014 May.
Article in English | MEDLINE | ID: mdl-24623105

ABSTRACT

The Department of Defense (DoD)-United States Food and Drug Administration (FDA) shelf-life extension program (SLEP) was established in 1986 through an intra-agency agreement between the DoD and the FDA to extend the shelf life of product nearing expiry. During the early stages of development, special attention was paid to program operation, labeling requirements, and the cost benefits associated with this program. In addition to the substantial cost benefits, the program also provides the FDA's Center for Drug Evaluation and Research with significant scientific understanding and pharmaceutical resource. As a result of this unique resource, numerous regulatory research opportunities to improve public health present themselves from this distinctive scientific database, which includes examples of products shelf life, their long-term stability issues, and various physical and chemical tests to identify such failures. The database also serves as a scientific resource for mechanistic understanding and identification of test failures leading to the development of new formulations or more robust packaging. It has been recognized that SLEP is very important in maintaining both national security and public welfare by confirming that the stockpiled pharmaceutical products meet quality standards after the "expiration date" assigned by the sponsor. SLEP research is an example of regulatory science that is needed to best ensure product performance past the original shelf life. The objective of this article is to provide a brief history and background and most importantly the public health benefits of the SLEP.


Subject(s)
Chemistry, Pharmaceutical/standards , Pharmaceutical Preparations/chemistry , Pharmaceutical Preparations/standards , Drug Packaging/standards , Drug Stability , Public Health/standards , United States , United States Food and Drug Administration
4.
AIDS Res Hum Retroviruses ; 29(6): 887-91, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23351216

ABSTRACT

The Centers for Disease Control (CDC) testing recommendations suggest universal opt-out testing in all health care settings, including cancer clinics. The incidence of non-AIDS-defining cancers (NADCs) is on the rise among HIV patients. However, to date, no data exist on the prevalence of HIV infection among NADC patients in the United States. Knowledge of HIV infection may affect clinical management, prognosis, and overall patient survival and decrease new infections in the population. The purpose of this study was to determine the point seroprevalence of HIV infection in cancer patients being seen in medical oncology clinics. A total of 634 individuals (mean age=53.2 years) participated and were tested for HIV. None of the participants tested positive for HIV in any of the three clinics. Using a futility analysis, the upper end of the 95% confidence interval for prevalence of undiagnosed HIV in cancer patients was less than 0.3%. Most participants were female (59.2%) and non-Hispanic (96.6%). The majority of study participants were white (76.5%) or African-American (17.7%). Breast cancer (19.7%), colon cancer (10.3%), and melanoma (9.7%) were the most commonly reported non-AIDS-defining cancers. While our study suggested that there was no occurrence of undiagnosed HIV among NADC patients, it is important to note that our population was largely white, females with insurance and with a different distribution of cancer than the most prevalent NADC among HIV patients. Furthermore, one-third of the patients did not consent to participate and further studies are needed to assess reasons for their unwillingness along with other populations, specifically minorities and individuals with low socioeconomic status (SES).


Subject(s)
HIV Infections/epidemiology , Neoplasms/virology , Breast Neoplasms/virology , Colonic Neoplasms/virology , Female , HIV Infections/complications , HIV Seroprevalence , Humans , Male , Melanoma/virology , Middle Aged , Neoplasms/epidemiology , United States/epidemiology
5.
Neuroendocrinology ; 96(2): 141-51, 2012.
Article in English | MEDLINE | ID: mdl-22576754

ABSTRACT

Anabolic androgenic steroids (AAS) comprise a large and growing class of synthetic androgens used clinically to promote tissue-building in individuals suffering from genetic disorders, injuries, and diseases. Despite these beneficial therapeutic applications, the predominant use of AAS is illicit: these steroids are self-administered to promote athletic performance and body image. Hand in hand with the desired anabolic actions of the AAS are untoward effects on the brain and behavior. While the signaling routes by which the AAS impose both beneficial and harmful actions may be quite diverse, key endpoints are likely to include ligand-gated and voltage-dependent ion channels that govern the activity of electrically excitable tissues. Here, we review the known effects of AAS on molecular targets that play critical roles in controlling electrical activity, with a specific focus on the effects of AAS on neurotransmission mediated by GABA(A) receptors in the central nervous system.


Subject(s)
Anabolic Agents/pharmacology , Neurons/metabolism , Synaptic Transmission/physiology , Testosterone Congeners/pharmacology , Animals , Brain/cytology , Humans , Ion Channels/metabolism , Neurons/drug effects , Receptors, GABA-A/metabolism , Steroids/metabolism , Synaptic Transmission/drug effects
6.
Hum Mol Genet ; 21(4): 730-50, 2012 Feb 15.
Article in English | MEDLINE | ID: mdl-22048958

ABSTRACT

We have identified a point mutation in Npc1 that creates a novel mouse model (Npc1(nmf164)) of Niemann-Pick type C1 (NPC) disease: a single nucleotide change (A to G at cDNA bp 3163) that results in an aspartate to glycine change at position 1005 (D1005G). This change is in the cysteine-rich luminal loop of the NPC1 protein and is highly similar to commonly occurring human mutations. Genetic and molecular biological analyses, including sequencing the Npc1(spm) allele and identifying a truncating mutation, confirm that the mutation in Npc1(nmf164) mice is distinct from those in other existing mouse models of NPC disease (Npc1(nih), Npc1(spm)). Analyses of lifespan, body and spleen weight, gait and other motor activities, as well as acoustic startle responses all reveal a more slowly developing phenotype in Npc1(nmf164) mutant mice than in mice with the null mutations (Npc1(nih), Npc1(spm)). Although Npc1 mRNA levels appear relatively normal, Npc1(nmf164) brain and liver display dramatic reductions in Npc1 protein, as well as abnormal cholesterol metabolism and altered glycolipid expression. Furthermore, histological analyses of liver, spleen, hippocampus, cortex and cerebellum reveal abnormal cholesterol accumulation, glial activation and Purkinje cell loss at a slower rate than in the Npc1(nih) mouse model. Magnetic resonance imaging studies also reveal significantly less demyelination/dysmyelination than in the null alleles. Thus, although prior mouse models may correspond to the severe infantile onset forms of NPC disease, Npc1(nmf164) mice offer many advantages as a model for the late-onset, more slowly progressing forms of NPC disease that comprise the large majority of human cases.


Subject(s)
Carrier Proteins/genetics , Disease Models, Animal , Membrane Glycoproteins/genetics , Niemann-Pick Disease, Type C/genetics , Point Mutation/genetics , Age of Onset , Alleles , Animals , Astrocytes/pathology , Brain/metabolism , Carrier Proteins/chemistry , Carrier Proteins/metabolism , Cholesterol/metabolism , DNA Mutational Analysis , Disease Progression , Endoplasmic Reticulum Stress , Gangliosides/metabolism , Homozygote , Humans , Intracellular Signaling Peptides and Proteins , Lipid Metabolism , Lung/cytology , Macrophages/metabolism , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/metabolism , Mice , Microglia/pathology , Myelin Sheath , Niemann-Pick C1 Protein , Niemann-Pick Disease, Type C/metabolism , Niemann-Pick Disease, Type C/pathology , Niemann-Pick Disease, Type C/physiopathology , Phenotype , Proteostasis Deficiencies , Purkinje Cells/pathology , RNA, Messenger/analysis , RNA, Messenger/genetics , Reflex, Startle , Survival Rate
7.
Neuropharmacology ; 61(4): 653-64, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21645530

ABSTRACT

Disruption of reproductive function is a hallmark of abuse of anabolic androgenic steroids (AAS) in female subjects. To understand the central actions of AAS, patch clamp recordings were made in estrous, diestrous and AAS-treated mice from gonadotropin releasing hormone (GnRH) neurons, neurons in the medial preoptic area (mPOA) and neurons in the anteroventroperiventricular nucleus (AVPV); regions known to provide GABAergic and kisspeptin inputs to the GnRH cells. Action potential (AP) frequency was significantly higher in GnRH neurons of estrous mice than in AAS-treated or diestrous animals. No significant differences in AAS-treated, estrous or diestrous mice were evident in the amplitude or kinetics of spontaneous postsynaptic currents (sPSCs), miniature PSCs or tonic currents mediated by GABA(A) receptors or in GABA(A) receptor subunit expression in GnRH neurons. In contrast, the frequency of GABA(A) receptor-mediated sPSCs in GnRH neurons showed an inverse correlation with AP frequency across the three hormonal states. Surprisingly, AP activity in the medial preoptic area (mPOA), a likely source of GABAergic afferents to GnRH cells, did not vary in concert with the sPSCs in the GnRH neurons. Furthermore, pharmacological blockade of GABA(A) receptors did not alter the pattern in which there was lower AP frequency in GnRH neurons of AAS-treated and diestrous versus estrous mice. These data suggest that AAS do not impose their effects either directly on GnRH neurons or on putative GABAergic afferents in the mPOA. AP activity recorded from neurons in kisspeptin-rich regions of the AVPV and the expression of kisspeptin mRNA and peptide did vary coordinately with AP activity in GnRH neurons. Our data demonstrate that AAS treatment imposes a "diestrous-like" pattern of activity in GnRH neurons and suggest that this effect may arise from suppression of presynaptic kisspeptin-mediated excitatory drive arising from the AVPV. The actions of AAS on neuroendocrine regulatory circuits may contribute the disruption of reproductive function observed in steroid abuse.


Subject(s)
Anabolic Agents/administration & dosage , Methyltestosterone/administration & dosage , Midline Thalamic Nuclei/drug effects , Preoptic Area/drug effects , Synapses/drug effects , Synaptic Potentials/drug effects , Animals , Female , Gonadotropin-Releasing Hormone/biosynthesis , Gonadotropin-Releasing Hormone/physiology , Mice , Mice, Transgenic , Midline Thalamic Nuclei/physiology , Neurons/metabolism , Preoptic Area/physiology , Synapses/physiology , Synaptic Potentials/physiology
8.
Psychoneuroendocrinology ; 35(10): 1473-85, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20537804

ABSTRACT

In the past several decades, the therapeutic use of anabolic androgenic steroids (AAS) has been overshadowed by illicit use of these drugs by elite athletes and a growing number of adolescents to enhance performance and body image. As with adults, AAS use by adolescents is associated with a range of behavioral effects, including increased anxiety and altered responses to stress. It has been suggested that adolescents, especially adolescent females, may be particularly susceptible to the effects of these steroids, but few experiments in animal models have been performed to test this assertion. Here we show that chronic exposure of adolescent female mice to a mixture of three commonly abused AAS (testosterone cypionate, nandrolone decanoate and methandrostenolone; 7.5 mg/kg/day for 5 days) significantly enhanced anxiety-like behavior as assessed by the acoustic startle response (ASR), but did not augment the fear-potentiated startle response (FPS) or alter sensorimotor gating as assessed by prepulse inhibition of the acoustic startle response (PPI). AAS treatment also significantly increased the levels of corticotropin releasing factor (CRF) mRNA and somal-associated CRF immunoreactivity in the central nucleus of the amygdala (CeA), as well as neuropil-associated immunoreactivity in the dorsal aspect of the anterolateral division of the bed nucleus of the stria terminalis (dBnST). AAS treatment did not alter CRF receptor 1 or 2 mRNA in either the CeA or the dBnST; CRF immunoreactivity in the ventral BnST, the paraventricular nucleus (PVN) or the median eminence (ME); or peripheral levels of corticosterone. These results suggest that chronic AAS treatment of adolescent female mice may enhance generalized anxiety, but not sensorimotor gating or learned fear, via a mechanism that involves increased CRF-mediated signaling from CeA neurons projecting to the dBnST.


Subject(s)
Anabolic Agents/pharmacology , Androgens/pharmacology , Anxiety/psychology , Corticotropin-Releasing Hormone/biosynthesis , Steroids/pharmacology , Amygdala/drug effects , Animals , Behavior, Animal/drug effects , Corticosterone/blood , Fear/psychology , Female , Habituation, Psychophysiologic/drug effects , Immunohistochemistry , Methandrostenolone/pharmacology , Mice , Mice, Inbred C57BL , Nandrolone/pharmacology , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Reflex, Startle/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Septal Nuclei/drug effects
9.
J Neurosci ; 30(19): 6497-506, 2010 May 12.
Article in English | MEDLINE | ID: mdl-20463213

ABSTRACT

Gonadotropin-releasing hormone (GnRH) neurons are the central regulators of reproduction. GABAergic transmission plays a critical role in pubertal activation of pulsatile GnRH secretion. Self-administration of excessive doses of anabolic androgenic steroids (AAS) disrupts reproductive function and may have critical repercussions for pubertal onset in adolescent users. Here, we demonstrate that chronic treatment of adolescent male mice with the AAS 17alpha-methyltestosterone significantly decreased action potential frequency in GnRH neurons, reduced the serum gonadotropin levels, and decreased testes mass. AAS treatment did not induce significant changes in GABAA receptor subunit mRNA levels or alter the amplitude or decay kinetics of GABAA receptor-mediated spontaneous postsynaptic currents (sPSCs) or tonic currents in GnRH neurons. However, AAS treatment significantly increased action potential frequency in neighboring medial preoptic area (mPOA) neurons and GABAA receptor-mediated sPSC frequency in GnRH neurons. In addition, physical isolation of the more lateral aspects of the mPOA from the medially localized GnRH neurons abrogated the AAS-induced increase in GABAA receptor-mediated sPSC frequency and the decrease in action potential firing in the GnRH cells. Our results indicate that AAS act predominantly on steroid-sensitive presynaptic neurons within the mPOA to impart significant increases in GABAA receptor-mediated inhibitory tone onto downstream GnRH neurons, resulting in diminished activity of these pivotal mediators of reproductive function. These AAS-induced changes in central GABAergic circuits of the forebrain may significantly contribute to the disruptive actions of these drugs on pubertal maturation and the development of reproductive competence in male steroid abusers.


Subject(s)
Anabolic Agents/toxicity , Gonadotropin-Releasing Hormone/metabolism , Methyltestosterone/toxicity , Neurons/drug effects , Receptors, GABA-A/metabolism , Substance-Related Disorders/physiopathology , Synaptic Transmission/drug effects , Action Potentials/drug effects , Action Potentials/physiology , Androgens/toxicity , Animals , Gonadotropins/blood , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hypothalamo-Hypophyseal System/drug effects , Hypothalamo-Hypophyseal System/physiopathology , Male , Mice , Mice, Transgenic , Neurons/physiology , Preoptic Area/drug effects , Preoptic Area/physiopathology , Presynaptic Terminals/drug effects , Presynaptic Terminals/physiology , RNA, Messenger/metabolism , Substance-Related Disorders/blood , Substance-Related Disorders/pathology , Synaptic Potentials/drug effects , Synaptic Potentials/physiology , Synaptic Transmission/physiology , Testis/drug effects , Testis/pathology
10.
J Neurosci ; 29(40): 12484-96, 2009 Oct 07.
Article in English | MEDLINE | ID: mdl-19812324

ABSTRACT

Anabolic androgenic steroids (AAS) can promote detrimental effects on social behaviors for which GABA type A (GABA(A)) receptor-mediated circuits in the forebrain play a critical role. While all AAS bind to androgen receptors (AR), they may also be aromatized to estrogens and thus potentially impart effects via estrogen receptors (ER). Chronic exposure of wild-type male mice to a combination of chemically distinct AAS increased action potential (AP) frequency, selective GABA(A) receptor subunit mRNAs, and GABAergic synaptic current decay in the medial preoptic area (mPOA). Experiments performed with pharmacological agents and in AR-deficient Tfm mutant mice suggest that the AAS-dependent enhancement of GABAergic transmission in wild-type mice is AR-mediated. In AR-deficient mice, the AAS elicited dramatically different effects, decreasing AP frequency, spontaneous IPSC amplitude and frequency and the expression of selective GABA(A) receptor subunit mRNAs. Surprisingly, in the absence of AR signaling, the data indicate that the AAS do not act as ER agonists, but rather suggest a novel in vivo action in which the AAS inhibit aromatase and impair endogenous ER signaling. These results show that the AAS have the capacity to alter neuronal function in the forebrain via multiple steroid signaling mechanisms and suggest that effects of these steroids in the brain will depend not only on the balance of AR- versus ER-mediated regulation for different target genes, but also on the ability of these drugs to alter steroid metabolism and thus the endogenous steroid milieu.


Subject(s)
Methyltestosterone/administration & dosage , Nandrolone/analogs & derivatives , Neurons/drug effects , Preoptic Area/drug effects , Receptors, Estrogen/metabolism , Receptors, GABA/drug effects , Testosterone/analogs & derivatives , Action Potentials/drug effects , Anabolic Agents/administration & dosage , Androgen Receptor Antagonists , Androgens/administration & dosage , Animals , Aromatase Inhibitors/pharmacology , Drug Combinations , Estradiol/metabolism , Estrogens/metabolism , Estrogens/pharmacology , Injections, Intraperitoneal , Male , Mice , Mice, Transgenic , Nandrolone/administration & dosage , Nandrolone Decanoate , Neurons/metabolism , Preoptic Area/cytology , Receptors, Androgen/administration & dosage , Receptors, Androgen/deficiency , Synaptic Transmission/drug effects , Testosterone/administration & dosage , Testosterone/metabolism
11.
Brain Res ; 1126(1): 122-38, 2006 Dec 18.
Article in English | MEDLINE | ID: mdl-17010954

ABSTRACT

Illicit use of anabolic androgenic steroids (AAS) has become a prevalent health concern not only among male professional athletes, but, disturbingly, among a growing number of women and adolescent girls. Despite the increasing use of AAS among women and adolescents, few studies have focused on the effects of these steroids in females, and female adolescent subjects are particularly underrepresented. Among the hallmarks of AAS abuse are changes in reproductive behaviors. Here, we discuss work from our laboratories on the actions of AAS on the onset of puberty and sexual behaviors in female rodents, AAS interactions and sex- and age-specific effects of these steroids on neural transmission mediated by gamma-aminobutyric acid receptors within forebrain neuroendocrine control regions that may underlie AAS-induced changes in these behaviors.


Subject(s)
Neurosecretory Systems/drug effects , Prosencephalon/drug effects , Reproduction/drug effects , Sexual Behavior, Animal/drug effects , Testosterone Congeners/adverse effects , gamma-Aminobutyric Acid/metabolism , Age Factors , Animals , Female , Humans , Neurosecretory Systems/growth & development , Neurosecretory Systems/metabolism , Prosencephalon/growth & development , Prosencephalon/metabolism , Puberty/drug effects , Puberty/metabolism , Receptors, GABA-A/drug effects , Receptors, GABA-A/metabolism , Reproduction/physiology , Sex Differentiation/drug effects , Sex Differentiation/physiology , Sexual Behavior, Animal/physiology
12.
Endocrinology ; 147(9): 4192-204, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16777973

ABSTRACT

Endocrine-disrupting compounds (EDCs) may interfere with neuronal development due to high levels of accumulation in biological tissue and potentially aberrant steroid signaling. Treatment of dissociated embryonic Xenopus spinal cord neurons with the EDC, nonylphenol (NP), did not alter cell survival or neurite outgrowth but inhibited neurotrophin-induced neurite outgrowth, effects that were recapitulated by treatment with comparable concentrations of 17 beta-estradiol (E2) and beta-estradiol 6-(O-carboxy-methyl)oxime: BSA (E2-BSA), but not a synthetic androgen. Effects of NP were not inhibited by the nuclear estrogen receptor antagonist, ICI 182,780, but were inhibited by the G protein antagonist, pertussis toxin. Nerve growth factor (NGF)-induced neurite outgrowth in Xenopus neurons was shown to require MAPK signaling. NP did not affect TrkA expression, MAPK signaling, or phosphatidylinositol 3' kinase-Akt-glycogen synthase kinase 3 beta (PI3K-Akt-GSK3 beta) signaling in Xenopus. The ability of NP to inhibit NGF-induced neurite outgrowth without altering survival was recapitulated in the rat pheochromocytoma (PC12) cell line. As with Xenopus neurons, the inhibitory actions of NP in PC12 cells were not antagonized by ICI 182,780 and did not involve alterations in signaling along either the MAPK or PI3K-Akt-GSK3 beta pathways. NP did significantly inhibit the ability of NGF to increase protein kinase A activity in this cell line. These data have important implications with respect to potentially deleterious effects of NP exposure during early neural development and highlight the fact that bioaccumulation of EDCs, such as NP, may elicit very disparate effects along divergent signaling pathways than those that arise from the actions of physiological levels of endogenous estrogens.


Subject(s)
Nerve Growth Factor/pharmacology , Neurites/drug effects , Phenols/pharmacology , Animals , Cell Differentiation/drug effects , Cell Survival/drug effects , Cells, Cultured , Cyclic AMP-Dependent Protein Kinases/metabolism , Estradiol/pharmacology , GTP-Binding Proteins/antagonists & inhibitors , Glycogen Synthase Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , Neurites/physiology , Neurites/ultrastructure , PC12 Cells , Pertussis Toxin/pharmacology , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats , Receptors, Estrogen/antagonists & inhibitors , Receptors, Estrogen/physiology , Signal Transduction/drug effects , Spinal Cord/cytology , Spinal Cord/embryology , Xenopus laevis/embryology
13.
J Pharm Sci ; 95(7): 1549-60, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16721796

ABSTRACT

The American Medical Association has questioned whether expiration dating markedly underestimates the actual shelf life of drug products. Results from the shelf life extension program (SLEP) have been evaluated to provide extensive data to address this issue. The SLEP has been administered by the Food and Drug Administration for the United States Department of Defense (DOD) for 20 years. This program probably contains the most extensive source of pharmaceutical stability data extant. This report summarizes extended stability profiles for 122 different drug products (3,005 different lots). The drug products were categorized into five groups based on incidence of initial extension failures and termination failures (extended lot eventually failed upon re-testing). Based on testing and stability assessment, 88% of the lots were extended at least 1 year beyond their original expiration date for an average extension of 66 months, but the additional stability period was highly variable. The SLEP data supports the assertion that many drug products, if properly stored, can be extended past the expiration date. Due to the lot-to-lot variability, the stability and quality of extended drug products can only be assured by periodic testing and systematic evaluation of each lot.


Subject(s)
Drug Stability , Pharmaceutical Preparations , United States , United States Food and Drug Administration , United States Government Agencies
14.
Clin Endocrinol (Oxf) ; 63(6): 676-82, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16343103

ABSTRACT

OBJECTIVE: We have identified a large kindred with multiple endocrine neoplasia 2A (MEN 2A) due to a mutation at RET codon 609 that results in a cysteine to serine substitution, a mutation previously identified in only one case in the literature. We characterized the clinical phenotype of the kindred and the biochemical mechanism of this new mutation. PATIENTS AND DESIGN: The index case, a 42-year-old woman, presented with pheochromocytoma. We screened 29 family members for the presence of the mutation. Of the 15 mutation-positive family members, 11 agreed to undergo further evaluation by physical examination, calcium and pentagastrin-stimulated calcitonin levels, measurement of urinary metanephrines, adrenal imaging and serum calcium levels. Biochemical characterization of the mutation was by transient transfection of human neuroblastoma cells and Western blot analysis. RESULTS: This kindred demonstrated an inheritance pattern consistent with autosomal dominant pheochromocytoma. Strikingly, no clinically evident case of medullary thyroid cancer (MTC) was observed among mutation-positive family members. Thyroidectomy in six cases revealed C-cell hyperplasia in all and microscopic MTC in two cases. Transfection experiments using human neuroblastoma cells showed that the mutant RET, unlike the wild-type receptor, is constitutively phosphorylated in the absence of ligand, and thus resembles other previously characterized MEN 2A mutations. CONCLUSIONS: The identification of a new mutation causing a MEN 2A phenotype that features pheochromocytoma and the surprising absence of clinically apparent MTC has significant implications for carriers of this mutation and provides further insights into the genotype-phenotype correlation in MEN 2A.


Subject(s)
Carcinoma, Medullary/genetics , Multiple Endocrine Neoplasia Type 2a/diagnosis , Pheochromocytoma/genetics , Point Mutation , Proto-Oncogene Proteins c-ret/genetics , Thyroid Neoplasms/genetics , Adolescent , Adult , Calcitonin/blood , Calcium , Carcinoma, Medullary/metabolism , Catecholamines/urine , Child , Codon , Female , Humans , Male , Metanephrine/urine , Middle Aged , Multiple Endocrine Neoplasia Type 2a/genetics , Pedigree , Pentagastrin , Pheochromocytoma/metabolism , Polymorphism, Restriction Fragment Length , Sequence Analysis, DNA , Thyroid Gland/pathology , Thyroid Neoplasms/metabolism , Vanilmandelic Acid/urine
15.
J Neurosci Res ; 74(5): 794-800, 2003 Dec 01.
Article in English | MEDLINE | ID: mdl-14635231

ABSTRACT

Voltage-gated sodium (Na(+)) channels typically contain a pore-forming alpha subunit and one or two auxiliary beta subunits. Although initial characterization of known alpha and beta subunits has been facilitated by expression in heterologous cells, to understand fully the differences between individual subunits and the functional consequences of selective subunit expression, there is a need to acutely manipulate expression in cells that endogenously express Na(+) channels. To this end, we have constructed a recombinant adenovirus containing a cDNA for a mouse Na(+) channel beta1 subunit with a yellow fluorescent protein fused to its C-terminus (Ad-beta1-EYFP), and with fluorescence microscopy detected beta1-EYFP expression in primary cerebellar neurons and Chinese hamster ovary (CHO) cells upon transduction with this adenovirus, including expression in the plasma membrane. Consistent with this, patch clamp recordings confirmed that Na(+) currents in CHO cells expressing mouse Na(v)1.4 alpha subunits were appropriately modified by the viral-mediated expression of beta1-EYFP subunits. The results demonstrate that adenoviral-mediated gene delivery can be used effectively to express epitope-tagged Na(+) channel subunits with properties similar to wild-type subunits, and suggest that Ad-beta1-EYFP will be a useful reagent for investigating Na(+) channels in a variety of excitable cell types, including neurons.


Subject(s)
Neurons/physiology , Sodium Channels/physiology , Transduction, Genetic , Adenoviridae/genetics , Animals , Bacterial Proteins , CHO Cells , Cell Membrane/physiology , Cell Membrane/ultrastructure , Cricetinae , Cricetulus , Immunohistochemistry , Luminescent Proteins , Membrane Potentials/physiology , Mice , Microscopy, Fluorescence , Neurons/ultrastructure , Neurons/virology , Patch-Clamp Techniques , Transduction, Genetic/methods , Transfection
16.
Virology ; 315(2): 425-37, 2003 Oct 25.
Article in English | MEDLINE | ID: mdl-14585346

ABSTRACT

In the search for an effective vaccine against the human immunodeficiency virus (HIV), novel ways to deliver viral antigens are being evaluated. One such approach is the use of nonreplicating viral vectors encoding HIV and/or SIV genes that are expressed after infection of host cells. Nonreplicating poliovirus vectors, termed replicons, that expressed HIV-1/HXB2 and SIVmac239 gag and various HIV-1 env genes from different clades were tested for immunogenicity and protective efficacy against intravenous challenge of pig-tailed macaques with SHIV-89.6P. To maximize both cellular and humoral immune responses, a prime-boost regimen was used. Initially, macaques were immunized four times over 35 weeks by either the intranasal and intrarectal or the intramuscular (im) route with mixtures of poliovirus replicons expressing HIV-1 gag and multiple env genes. Immunization with replicons alone induced both serum antibodies and lymphocyte proliferative responses. After boosting with purified Env protein, neutralizing antibodies to SHIV-89.6P were induced in four of five immunized animals. In a second experiment, four macaques were immunized im three times over 27 weeks with replicons expressing the SIVmac239 gag and HIV-1/HXB2 env genes. All immunized animals were then boosted twice with purified HIV-1-89.6 rgp140-Env and SIVmac239 p55-Gag proteins. Four control animals received only the two protein inoculations. Immunized and control animals were then challenged intravenously with the pathogenic SHIV-89.6P. After challenge the animals were monitored for virus isolation from peripheral blood mononuclear cells and plasma viremia and for changes in virus-specific antibody titers. Naïve pig-tailed macaques experienced rapid loss of CD4(+) T cells and died between 38 and 62 weeks after infection. In contrast, macaques immunized with replicons and proteins rapidly cleared plasma virus and did not experience sustained loss of CD4(+) lymphocytes. Furthermore, two of the four macaques that were immunized only with purified proteins maintained high viral burdens and lost greater than 95% of their CD4(+) lymphocytes within 2 to 4 weeks after challenge. Thus, poliovirus replicons expressing HIV-1 and SIV antigens were immunogenic in pig-tailed macaques and appeared to enhance the protective effects observed after administration of purified proteins alone.


Subject(s)
Gene Products, env/immunology , Gene Products, gag/immunology , HIV-1/immunology , Poliovirus/genetics , Replicon/immunology , SAIDS Vaccines/immunology , Simian Acquired Immunodeficiency Syndrome/prevention & control , Vaccines, Synthetic/immunology , Animals , CD4 Lymphocyte Count , Female , Immunization , Interferon-gamma/biosynthesis , Interleukin-12/biosynthesis , Macaca nemestrina , Male , env Gene Products, Human Immunodeficiency Virus
17.
Horm Behav ; 43(4): 454-64, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12788291

ABSTRACT

ICI 182,780 (ICI) is a pure antiestrogen that when administered systemically does not cross the blood-brain barrier, thus its actions are limited to the periphery. Four experiments were conducted to test the effects of ICI on the display of sexual behaviors in ovariectomized rats. Experiment 1 examined the effects of three doses of ICI (250, 500, and 750 micro g/rat) on sexual receptivity and paced mating behavior in rats primed with estradiol benzoate (EB) in combination with progesterone (P). Experiments 2 and 3 compared the display of sexual behaviors in rats primed with EB+P or EB alone and administered either 250 micro g ICI (Experiment 2) or 500 micro g ICI (Experiment 3). Experiment 4 tested the effects of ICI (250 and 500 micro g) on the expression of estrogen-induced progestin receptors in the uterus. ICI did not affect the display of sexual receptivity in any experiment. In rats primed with EB+P, paced mating behavior was altered by the 500 and 750 micro g, but not the 250 micro g, doses of ICI. The lowest (250 micro g) dose of ICI did alter paced mating behavior in rats primed with EB alone. The effects of ICI on paced mating behavior were manifested by a substantial lengthening of contact-return latencies following intromissions and ejaculations. The percentage of exits were not affected by ICI. Estrogen stimulation of uterine weight and induction of uterine progestin receptors was suppressed by ICI (250 and 500 micro g). ICI effects on paced mating behavior in hormone-primed female rats are likely to reflect antiestrogenic actions in the periphery, including interference with the estrogen induction of progestin receptors.


Subject(s)
Estradiol/analogs & derivatives , Estradiol/pharmacology , Estrogen Antagonists/pharmacology , Sexual Behavior, Animal/drug effects , Animals , Dose-Response Relationship, Drug , Female , Fulvestrant , Male , Organ Size , Ovariectomy , Progesterone/pharmacology , Rats , Rats, Long-Evans , Reaction Time/drug effects , Uterus/anatomy & histology
18.
Environ Health Perspect ; 111(4): 488-96, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12676604

ABSTRACT

A growing number of environmental toxicants found in pesticides, herbicides, and industrial solvents are believed to have deleterious effects on development by disrupting hormone-sensitive processes. We exposed Xenopus laevis embryos at early gastrula to the commonly encountered environmental estrogens nonylphenol, octylphenol, and methoxychlor, the antiandrogen, p,p-DDE, or the synthetic androgen, 17 alpha-methyltestosterone at concentrations ranging from 10 nM to 10 microM and examined them at tailbud stages (approximately 48 hr of treatment). Exposure to the three environmental estrogens, as well as to the natural estrogen 17 beta-estradiol, increased mortality, induced morphologic deformations, increased apoptosis, and altered the deposition and differentiation of neural crest-derived melanocytes in tailbud stage embryos. Although neural crest-derived melanocytes were markedly altered in embryos treated with estrogenic toxicants, expression of the early neural crest maker Xslug, a factor that regulates both the induction and subsequent migration of neural crest cells, was not affected, suggesting that the disruption induced by these compounds with respect to melanocyte development may occur at later stages of their differentiation. Co-incubation of embryos with the pure antiestrogen ICI 182,780 blocked the ability of nonylphenol to induce abnormalities in body shape and in melanocyte differentiation but did not block the effects of methoxychlor. Our data indicate not only that acute exposure to these environmental estrogens induces deleterious effects on early vertebrate development but also that different environmental estrogens may alter the fate of a specific cell type via different mechanisms. Finally, our data suggest that the differentiation of neural crest-derived melanocytes may be particularly sensitive to the disruptive actions of these ubiquitous chemical contaminants.


Subject(s)
Androgen Antagonists/adverse effects , Cell Differentiation/drug effects , Estradiol Congeners/adverse effects , Water Pollutants, Chemical/adverse effects , Xenobiotics/adverse effects , Xenopus laevis/embryology , Animals , Congenital Abnormalities/etiology , Congenital Abnormalities/veterinary , Drug Interactions , Embryo, Nonmammalian/drug effects , Embryonic Development , Endocrine System/drug effects , Gene Expression Regulation, Developmental , Melanocytes/physiology , Neural Crest/embryology , Xenopus laevis/growth & development
19.
J Neurobiol ; 55(3): 355-71, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12717704

ABSTRACT

To understand the molecular basis of nervous system function in the leech, Hirudo medicinalis, we have isolated four novel cDNAs encoding putative voltage-gated sodium (Na) channel alpha subunits, and have analyzed the expression of these genes in individual neurons of known function. To begin, degenerate oligonucleotide primers were used in combination with pre-existing cDNA libraries and reverse transcriptase-coupled polymerase chain reactions (RT-PCR). The putative leech Na channel cDNAs (LeNas) exhibit a higher degree of sequence homology to Na channel genes in other species than to voltage-gated calcium or potassium channel genes, including those expressed in leech. All LeNa cDNAs contain sequences corresponding to regions of functional importance in Na channel alpha subunits, including the "S4 region" involved in activation, the "pore loops" responsible for ion selectivity, and the "inactivation loop" between the third and fourth domains, though the latter lacks the highly conserved "IFM" motif critical for mammalian Na channel inactivation. Sequences corresponding to important determinants of tetrodotoxin sensitivity are found in some, but not all, LeNa cDNAs, consistent with prior electrophysiological evidence of Na channel heterogeneity in the leech with respect to this toxin. Subsequently, two different sets of isoform-specific primers and methods of RT-PCR, including a sensitive, fluorescence-based "real time" RT-PCR, were used to analyze LeNa isoform expression in functionally distinct neurons. The results from both approaches were consistent, and not only demonstrated that individual neurons often express more than one LeNa isoform, but also revealed cell-specific patterns of Na channel isoform expression in the leech nervous system.


Subject(s)
Gene Expression , Leeches/genetics , Neurons/physiology , Sequence Analysis, Protein , Sodium Channels/genetics , Amino Acid Sequence , Animals , Cloning, Molecular , DNA, Complementary/analysis , Ion Channel Gating/genetics , Molecular Sequence Data , Protein Isoforms/genetics , Protein Subunits/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Sodium Channels/isolation & purification , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...